BSE filing, NSE: NUVOCO. Summary written from the filing by ALFA Finder's alert engine.
Nuvoco Vistas Corporation Ltd: key numbers
- Share price
- ₹332.30
- Market cap
- ₹11,868 Cr
- Revenue (annual)
- ₹11,338 Cr
- Net profit (annual)
- ₹359.4 Cr
- P/E (TTM)
- 28.6×Sector 31.7×
- Promoter holding
- 72.02%+0.00% QoQ
- FII holding
- 4.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nuvoco Vistas Corporation Ltd
All →Nuvoco Vistas Corporation Earnings Call Transcript: Key Takeaways
Nuvoco delivered resilient volume growth despite severe monsoon headwinds and significant fuel cost spikes.
Nuvoco Vistas Corporation Investor Presentation: Key Takeaways
Nuvoco reports 9% YoY volume growth and 11% EBITDA growth in Q2 FY27. Strategy focuses on premiumization (45% trade mix) and capacity expansion to 35 MMTPA via Vadraj acquisition.
Nuvoco Vistas Corporation Results Update
Nuvoco Vistas reported Q2 FY27 financial results with Rs 2,790 Cr revenue and Rs 411 Cr EBITDA, while commissioning 2 MMTPA grinding capacity in Surat.
- cement grinding capacity
- 2.0 MMTPA
Nuvoco Vistas Corporation Q2 FY27 Results: Net Profit ₹64.8 Cr, Up 78.0% YoY
Nuvoco Vistas Corporation Ltd reported revenue from operations of ₹2,790 Cr (+13.5% YoY) and net profit of ₹64.8 Cr (+78.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹64.8 Cr · +78.0% YoY
Nuvoco Vistas Corporation Merger & Restructuring
Nuvoco Vistas' Board approved the voluntary liquidation of its wholly-owned subsidiary, Algebra Endeavour Private Limited, to simplify the Group's structure.
Nuvoco Vistas Corporation Business Update
Nuvoco marks a decade of growth in a commemorative press release. The company operates 27 MMTPA cement capacity across 14 units and 58 RMC plants.
- cement capacity
- 27 MMTPA
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.